Supernus Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SUPN and other ETFs, options, and stocks.

About SUPN

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. 

CEO
Jack A. Khattar
CEOJack A. Khattar
Employees
575
Employees575
Headquarters
Rockville, Maryland
HeadquartersRockville, Maryland
Founded
2005
Founded2005
Employees
575
Employees575

SUPN Key Statistics

Market cap
1.92B
Market cap1.92B
Price-Earnings ratio
55.96
Price-Earnings ratio55.96
Dividend yield
Dividend yield
Average volume
353.00K
Average volume353.00K
High today
$35.89
High today$35.89
Low today
$35.32
Low today$35.32
Open price
$35.62
Open price$35.62
Volume
185.84K
Volume185.84K
52 Week high
$37.89
52 Week high$37.89
52 Week low
$24.95
52 Week low$24.95

SUPN Earnings

$0.00
$0.14
$0.29
$0.43
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 28, After Hours
ActualExpected Feb 28, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.